GRASP brings patients and researchers together for small-group conversations that make cancer science more accessible, collaborative, and deeply informed by patient experience.
The Metastatic Breast Cancer Research Conference (MBCRC21) is an annual meeting sponsored by Theresa’s Research Foundation, Baylor College of Medicine, and Huntsman Cancer Institute. MBCRC the only conference to bring expert researchers from around the world with a specific focus on metastatic breast cancer. GRASP is the official advocacy program of the MBCRC21 Annual Conference! Registration for […]
In this session, Dr. Meenakshi Anurag will discuss her research on triple-negative breast cancer (TNBC), focusing on the molecular mechanisms behind chemotherapy resistance. Through proteogenomic analysis, her lab has identified key biomarkers, such as LIG1 and POLD1, linked to treatment outcomes in TNBC. Join us to explore how these insights aim to enhance personalized treatment […]
The 2021 San Antonio Breast Cancer Symposium (SABCS) will be held on December 7-10, 2021. GRASP is one of the official advocacy programs of the SABCS21 Conference! Registration for the SABCS conference is free for patient advocates. The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education […]
GRASP will be held in conjunction with the 2022 American Society of Clinical Oncology (ASCO) annual meeting which is attended by more than 40,000 oncology professionals from around the world to discuss the latest advancements in cancer care treatments. GRASP brings scientists and patient advocates together for a personalized discussion about a scientific poster. Less like a presentation, and […]
Dr. Meenakshi Anurag will lead this session, sharing findings from her recent study on male breast cancer, a rare but critical area of research. Using multi-omics and big data analysis, Dr. Anurag’s work delves into the molecular heterogeneity of male breast cancer, identifying key genetic mutations and proteomic markers that could inform more personalized treatment […]
Dr. Senthil Damodaran will discuss her ASCO22 poster “Open-Label, Phase 2, Multicenter Study of Lasofoxifene (LAS) Combined with Abemaciclib (Abema) for Treating Pre-and Postmenopausal Women with Locally Advanced or Metastatic ER+/HER2− Breast Cancer and an ESR1Mutation After Progression on Prior Therapies.” She will share Sermonix Pharmaecuticals’ findings of the ELAINE-2 study, which explored the combination […]
The Metastatic Breast Cancer Research Conference (MBCRC22) will take place Sept 7-9th, 2022. MBCRC22 is an annual meeting sponsored by Theresa’s Research Foundation, Baylor College of Medicine, and Huntsman Cancer Institute. MBCRC is uniquely focused on metastatic breast cancer thereby distinguishing it from other breast cancer-centered conferences. GRASP is the official advocacy program of MBCRC22 […]
Join Dr. Jessica Christenson, Ph.D., a cancer biologist from the University of Colorado Anschutz Medical Campus, as she discusses her cutting-edge research on lung metastases in breast cancer. Dr. Christenson’s work focuses on how the lung promotes metastatic growth and how therapies used for asthma and chronic inflammation could be repurposed for metastatic patients. This […]
Dr. Traci Bethea, Ph.D. will discuss preliminary data and potential research projects related to personal care product use and environmental exposures among Black cancer survivors and treatment of insomnia symptoms among Black cancer survivors. In this discussion, we will cover the following studies: – A feasibility study of exposure to environmental chemicals among Black and […]
The Metastasis Research Society will hold its 19th Biennial Congress of the Metastasis Research Society (MRS) in-person in Buenos Aires, Argentina from November 13-16, 2022. The mission of the Metastasis Research Society is to advance anti-metastasis research that translates to improved metastatic patient outcomes and quality of life, and enables metastatic patients to make more informed treatment decisions […]
The 2022 San Antonio Breast Cancer Symposium (SABCS) will be held on December 6-10, 2022. This year’s SABCS conference will be held as a hybrid conference with both in-person events and live web streaming. The Symposium aims to achieve a balance of clinical, translational, and basic research, providing a forum for interaction, communication, and education for […]
Dr. Justin Johnson, Ph.D. and Dr. G. Thomas Budd, M.D. will provide us with the status and progress of the phase 1 trial of an alpha-lactalbumin vaccine in patients with operable triple-negative breast cancer.
GUIDING RESEARCHERS & ADVOCATES TO SCIENTIFIC PARTNERSHIPS